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Background: Bile acids (BA) are elevated in liver disease and are known liver tumor 
promoters. BAs induce expression of the scaffolding protein IQGAP1, which is 
overexpressed in numerous cancers. However, the contribution of IQGAP1 in BA-
induced tumorigenesis is unknown. 
Objective: To examine role for IQGAP1 in liver proliferation and tumor development. 
Methods: Adult male WT and Iqgap1-/- mice were fed either a 1% cholic acid (CA) diet 
(mild) or a 0.1% 3,5-diethyoxycarbonyl-1,4-dihydrocollidine (DDC) diet (severe) for two 
weeks to study liver injury. Another cohort of mice were treated with 10 mg/kg 
diethylnitrosamine (DEN), a liver carcinogen, at 2 weeks and aged to 52 weeks. Serum 
and livers were collected for biochemical, histological, and gene expression analysis. 
Results: CA and DDC treatments robustly induced hepatic IQGAP1 expression in WT 
mice and suggest a dose-effect. Importantly, loss of IQGAP1 did not alter BA 
metabolism, validating our previous data that IQGAP1 functions downstream of BAs. 
Iqgap1-/- mice fed CA diet showed reduced hepatic proliferation, whereas ectopic 
expression of IQGAP1 in Iqgap1-/- livers restored BA-induced proliferation. The DDC 
diet resulted in elevated serum BAs and total bilirubin, which was higher in Iqgap1-/- 
mice. Consistently, histological analysis revealed liver damage including increased 
inflammation and fibrosis along with increased BA accumulation in the livers of Iqgap1-/- 
mice.  
Conclusion: The short-term role for IQGAP1 downstream of BA signaling includes 
controlling hepatic proliferation, maintaining biliary homeostasis and protecting against 
injury. Therefore, analysis of DEN-treated Iqgap1-/- mice with and without CA should 
reveal an important role for IQGAP1 in tumor promotion and initiation downstream of BA 
signaling.  
 
